Data on KLK6, KLK7, KLK8, and KLK10 in MS are limited, but their regulation in neuroinflammatory contexts indicates possible synergistic or modulatory effects within the CNS protease network [251]. This evidence concerns the gene KLK6 and myeloid sarcoma.